1/50
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
PHARMACOLOGY
The study of substances that interact with living systems
through chemical processes.
• The study of drugs or medication action.
(pharmakon) (logia)
The word pharmacology is derived from Greek
φάρμακον, (__________), “drug, poison” and -λογία, -
(_____), “study of”, “knowledge of”
Paracelsus
“All drugs are poisons; the benefit depends on the
dosage.”
(PHARMACOTHERAPEUTICS) (Medical Pharmacology)
(_______________________)
• aka (_____________)
• The science of substances used to prevent, diagnose,
and treat disease.
• Example: When a person is taking paracetamol
(TOXICOLOGY) (study of poisons)
(_____________)
• The branch of pharmacology that deals with the
undesirable effects of chemicals on living systems, from
individual cells to humans to complex ecosystems.
• The (___________) (its nature, effects and detection).
• Example: When a person is taking too much paracetamol
(DRUGS) (treatment, prevention, or
diagnosis) (10918)
(________)
refer to pharmaceutical products that pertain to
chemical compounds or biological substances, other than
food, intended for use in the (______, ______, _______) of disease in humans or animals.
• (See Pharmacy Law, R.A. (______)
(GENERIC NAME) (Common name) (General Name) (Non-proprietary name) (Official Name)
(_______________)
• (___________) or (_______)
• Assigned to a drug usually based on the chemical name
• Also known as (________________)
• Example: ibuprofen, cetirizine, amoxicillin
• Usually related to (__________) **
o Drug name that appears on the official reference [i.e.
United States Pharmacopeia (USP) – National
Formulary (NF)]
o All drugs in the world are listed down in
Pharmacopeias
(tests, procedures, and acceptance criteria) (strength, quality, and purity) (official name) (generic name)
ROLE OF USP-NF MONOGRAPH
• USP-NF monographs contain specifications (____, ______, _______) that helps ensure
the (______, _____, ______) of named items.
• Drugs available in the Philippines, generally follow
USP-NF.
• Usually the (________) found in the USP-NF is also
the (________) of the drug.
(TRADE NAME) (Brand Name) (Proprietary Name) (Counterfeit drugs) (® (registered)) (TM (Trade Mark))
(__________)
• Also known as (_______) or (__________)
• The name which pharmaceutical company adapt to their
particular drug product.
• Copyrighted by and exclusive to the company.
• (__________) – drugs made by anybody who is not
part of the company; a copycat (these people should be
sued)
• Usually have the (_________) or (______________)
symbol on drug labels.
(Montelukast) (Kastair ®) (Unilab)
Generic Name: (_______)
Brand Name: (_________)
Company: (___________)

(Metformin HCI) (N/A) (Ritemed)
Generic Name: (_______)
Brand Name: (_________)
Company: (___________)

(Phenyleprine, Chlorpheneramine Maleate, Paracetamol) (Neozep Forte) (Unilab)
Generic Name: (_______)
Brand Name: (_________)
Company: (___________)

(Unibranded generics) (Combination Drug) (Forte) (Tablet) (Capsule) ()
• (___________) → named after the corporation,
they bear only the name of their corporation or company
(eg. RiteMed, Watsons, Rhea generics, TGP generics)
• Note: There are cases of (__________) products.
Where there are 2 or more generic names.
• (_______) → drowsy; usually added to the name if a drug is
improved or something is added to it
• (_______) → takes time to dissolve in the body
• (_______) → absorbed much faster compared to tablet
(CHEMICAL NAME) (N-acetyl-para-aminophenol) (C8H9NO2)
(____________)
• The exact molecular formula of the drug.
• Complete (1) (__________) of the drug.
• Usually, a very long name and difficult to pronounce.
• Example:
o Generic Name: Paracetamol
o Brand Name: Tempra
o Chemical Name: (________________)
(APAP) [para means opposite]
o Chemical Formula: (_________)
(No difference) (No difference) (Higher in cost) (Lower in cost)
(Covered if no Generic Form Exists) (Normally always covered) (Tested and
approved by the FDA) (May Differ – but proven to be acceptable by the FDA) (No difference) (No difference) (Drugs are standard in size, color, packaging,
etc.)
(Packaging and drug itself may look different)
SIMILARITIES AND DIFFERENCES OF GENERIC
VS BRANDED DRUGS
BRAND NAME | GENERIC DRUGS | |
Active Pharmaceutical Ingredient | (_________) | (________) |
Price | (_________) | (________) |
Insurance Coverage | (________) | (_______) |
Inactive Ingredients | (________) | (_______) |
Strength / Dosage | (_______) | (_______) |
Appearance / Look | (_______) | (________) |
CHEMICAL GROUP
• Drugs that are classified based on the chemical structure.
• What structure is common or similar in the different drugs
• If they have the same functional groups, the activity would
be almost similar.
• β-lactam antibiotics
o Penicillins, Cephalosporins, Monobactams,
Carbapenems (all contain β-lactam ring) (Cell Wall
Synthesis Inhibitors)
• Note: The similarity on the chemical structure will equate
to the similarity of their use or their effect.
(MECHANISM OF ACTION) (specific biological target.) (site of action) (receptors) (Enzyme inducer) (activator) (inhibitor) (catalysts) (vasoconstriction) (Ion channel) (Calcium) (Calcium channel blocker (Dihydropyridine)
(___________)
Drug classes that share a common molecular mechanism
of action by modulating the activity of a (___________)
• Also known as (_________)
o For (_______), these activities include agonist
(activates the cell), antagonist (opposes the effect),
inverse agonist, or modulator.
o (________) → if an enzyme in the body is
activated by a drug
o Enzyme target mechanisms include (_______) or
(_______). Enzymes act as (________); they speed up
chemical reactions in the body.
§ Too much Angiotensin II (causes
(_______) can lead to hypertension.
o (________) modulators include opener or blocker.
o Sodium can enter through the Sodium-Potassium
pump, Calcium can enter through Calcium Ion
Channels, and so there are drugs that can open a
channel to allow entry/close an Ion channel.
o (________) – is a drug that when it enters the blood
vessels, it will lead to vasoconstriction.
o The (___________________________)
blocks the calcium so that it won’t enter thus causing
vasodilation. If calcium enters the heart, it will lead to
muscular contraction.
• -ase → enzyme; -ose → sugar
(PRIMARY EFFECT) (anatomical or functional)
(___________)
o Drug classes that are categorized by the (_____________) change the drugs induced.
o Groupings of the drug based on physiological
change
(Diuretic or Antidiuretic) (Inotrope (positive or negative) (Chronotrope (positive or negative) (Bronchodilator) (Decongestant) (Sedative)
§ (____________) – increases or
decreases the production of urine; diuresis =
urination
§ (_______________) – affects the
force of contraction of the heart by the cardiac
muscles
§ (_________________) – if the drug
increases or decreases the beat of the heart
muscle (bpm)
§ (_____________) – makes the bronchioles (air
passageways) dilate
§ (____________) – remove the clogs or
congestions in the airways
§ Antithrombotics
§ (____________) – producing sleep
THERAPEUTIC EFFECT
(__________________)
o Drug classes that are categorized by the pathology
the drugs treat.
o Grouped according to the pathology treated by the
drug
(OTC DRUGS or Over-the-counter drugs)
• (_____________________); no purchasing restrictions by
the FDA.
• These drugs can be bought without prescription.
• Can be seen in groceries or drug stores; such as
paracetamol
(PRESCRIPTION DRUGS) (Legend drugs)
(_______________)
• Also known as (___________);
• Determined unsafe for OTC purchase due to possible
adverse effects if taken without physician’s advice.
• FDA has deemed it necessary for the patient to seek a
physician first before purchasing this (1) (____________).
• Buying this drug requires (1) (_______________).
(CONTROLLED SUBSTANCES) (Drug controlled)
(______________________)
(__________________) by a special prescription requirement
because of the danger of addiction or abuse.
(PDEA) (FDA) (C-I) (C-V)
• Controlled by the (______) and the (______).
• These drugs are classified through schedule numbers (_______) to (________). As the number increases, the less prone it is for abuse and physical dependence.
PRESCRIPTION DRUGS
Products that bear the
Rx symbol in their
packaging requires
prescription.
OTC DRUGS
• Products with no Rx on
the packaging, can be
dispensed w/o
prescription.
• Pharmacy counseling
is recommended.
(C-I)
Controlled substance
• In the Philippines, there is no law regulating the use of
Marijuana. Thus, it is classified as (_____).
• As the number of the classification increases, the risk of
drug abuse and dependency is reduced.
(S-2 license)
CONTROLLED SUBSTANCES
• Have a distinct symbol on its label.
• It requires a special prescription from a physician with
valid (_______) issued by PDEA.
DRUG ACTIONS
• These are terms you usually find when searching about
drug information (i.e.: Text book, PPD, MIMS, Drug
leaflets)
• It is easier to find specific information once you
understand what is listed under each heading.
INDICATIONS
• Contains the list of medical conditions or disease for
which the drug is meant to be used.
• What the drug is used for.
ACTIONS
• Contains the description of cellular changes occurs as a
result of the drug.
• What change the drug produces in the body to treat the
condition.
CONTRAINDICATIONS
• Contains the list of conditions for which the drug should
not be used.
CAUTIONS
• Contains the list of conditions or patient types that
demands closer observation for specific side effects
when given the drug.
(SIDE EFFECTS OR ADVERSE DRUG REACTIONS) (drowsiness)
(________________)
• Contains the list of unintended, unpleasant, or dangerous
secondary effects other than the desired effect of the
drug.
Example: Benadryl can cause (______)
INTERACTIONS
• Contains the list of other drug or specific food that may
alter the effect of the drug, generally should not be given
during the course of therapy.
• You will know what not to take together with the drug.
(PHARMACOKINETICS) absorption,
distribution, metabolism, and excretion (ADME).
(______________)
The study of the time course of drug (_____, _______, _______, ________)
• It answers the question: “what does the body do to the
drugs?”
• Describes the movement of drugs through the body.
PHARMACODYNAMICS
refers to the relationship between
drug concentration at the site of action and the
resulting effect, including the time course and intensity
of therapeutic and adverse effects.
• It answers the question: “what does the drug do to the
body?”
• Describes the body’s biological response to drugs.
PLANTS
• Considered as the primary source of drugs, where
active ingredients are extracted from bark, leaves, resin,
roots, fruits and flowers of a plant.
• Example: Lagundi for cough, Oregano leaves for cough,
Sambong for urolithiasis
(ANIMALS) (cows) (pork or pig)
(_________)
• Lacking substances in the human body can be replaced
with similar substances found in glands, organs and
tissues of animals (including humans, microorganisms).
• Drugs can also be obtained from fungi (such as
Penicillin), algae, and other living organisms.
• Example: Bovine insulin from (_______), Porcine insulin from
(___________)
MINERALS
• Substances that are found in earth and soil.
SYNTHETIC
• Drugs that are manufactured in laboratories using
advance human skills and understanding of chemistry.
SYSTEMIC EFFECT
• Drug effect that reaches widespread areas of the body.
• Usually occurs when drug reaches the blood stream.
• Example: pain relievers distributed all throughout the
body, antibiotics given in the IV.
(NATURE OF DRUGS) (“fit”)
(________________)
• To have a good (____) to only one type of receptor, a drug
molecule must be sufficiently unique in shape, charge,
and other properties to prevent its binding to other
receptors.
• It is very important for drugs to bind to our receptor.
(DRUG SIZE) (1000 g/mol) ()
(___________)
• Ave. molecular weight of drugs is between 100 and 1000
g/mol.
• To achieve such selective binding, it appears that a
molecule should in most cases be at least 100 g/mol in
size.
• The upper limit in molecular weight is determined
primarily by the requirement that drugs must be able to
move within the body (eg, from the site of administration
to the site of action).
• Note: Drugs much larger than (________) do not diffuse
readily between compartments of the body.
(DRUG REACTIVITY & DRUG-RECEPTOR BONDS)
(covalent, electrostatic, and hydrophobic bond.)
(___________________&_______________________)
• Drugs interact with receptors by means of chemical
forces or bonds.
• These are of three major types: (_______, ________, ___________)
(Covalent bonds) (covalently)
• (___________) are very strong and, in many cases, not
reversible under biologic conditions.
o If a drug binds to a receptor (_________), it is very
difficult for it to be reversed because it is strong and
irreversible.
(Electrostatic bonding)
• (_____________) is much more common bonding
in drug-receptor interactions.
o It varies from relatively strong linkages between
permanently charged ionic molecules to weaker
hydrogen bonds and very weak induced dipole
interactions such as van der Waals forces and similar
phenomena.
o A bond for charged molecules.
(Hydrophobic bonds) (“pockets.”)
(______________)
are usually quite weak and are
probably important in the interactions of highly lipid-
soluble drugs with the lipids of cell membranes and
perhaps in the interaction of drugs with the internal walls
of receptor (_________)
o For drugs that are fat-based.
(DRUG SHAPE) (chirality)
(_____________)
molecule must be such as to permit
binding to its receptor site via the bonds just described.
• is complementary to that of the receptor
site in the same way that a key is complementary to a
lock.
• The phenomenon of (_______) (stereoisomerism) is so
common in biology that more than half of all useful drugs
are chiral molecules; that is, they can exist as
enantiomeric pairs.
(enantiomer) (Active site)
o An (________) of a drug may vary in terms of
receptor selectivity, potency and intrinsic activity.
• (___________) → site where the substrate bonds